Utility of the Asia-Pacific colorectal screening scoring system and the presence of metabolic syndrome components in screening for sporadic colorectal cancer

doi:10.3748/wjg.v20.i32.11394

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 32

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6477)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-3) series.

Item

Count

PDF

456

WORD

217

HTML

3591

Tables (1-3)

474

Sum=4738

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

829

Download

910

Sum=1739

Aug 28, 2014 (publication date) through Oct 31, 2025

Times Cited of This Article

Times Cited (13)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Observational Study

World J Gastroenterol. Aug 28, 2014; 20(32): 11394-11399
Published online Aug 28, 2014. doi: 10.3748/wjg.v20.i32.11394

Table 1 Comparison of the colorectal tumor detection rates in patients in the different Asia-Pacific colorectal screening risk groups n (%)

Groups	AR (n = 88)	MR (n = 113)	HR (n = 18)
Colorectal tumor	14 (15.9)	41 (36.3)^b	14 (77.8)^b^d
Non-advanced tumor	12 (13.6)	30 (26.5)^a	9 (50)^b^c
Advanced tumor	2 (2.3)	11 (9.7)^a	5 (27.8)^b^c

^aP < 0.05,

^bP < 0.01 vs AR group;

^cP < 0.05,

^dP < 0.01 vs MR group. AR: Average-risk; MR: Moderate-risk; HR: High-risk.

Full Size Table

Table 2 Effect of the presence of metabolic syndrome components on the colorectal tumor detection rate n (%)

Groups	A (n = 52)	B (n = 39)	C (n = 40)	B + C (n = 79)
Colorectal tumor	10 (19.2)	22 (56.4)^b	25 (62.5)^b	47 (59.5)^b
Non-advanced tumor	9 (17.3)	14 (35.9)^a	16 (40)^a	30 (38.0)^a
Advanced tumor	1 (1.9)	8 (20.5)^b	9 (22.5)^b	17 (21.5)^b

^aP < 0.05,

^bP < 0.01 vs group A.

Full Size Table

Table 3 Comparison of the colorectal tumor detection rates for different screening programs n (%)

Groups	Patient volunteered (D) (n = 41)	Doctor recommended (E) (n = 126)	APCS MR/HR (F) (n = 131)	APCS MR/HR with obesity (G) (n = 79)
Colorectal tumor	6 (14.6)	46 (36.5)^b	55 (42.0)^b	47 (59.5)^b^d^e
Non-advanced tumor	5 (12.2)	33 (26.2)	39 (29.8)^a	30 (38.0)^b
Advanced tumor	1 (2.4)	13 (10.3)	16 (12.2)	17 (21.5)^b^c

^aP < 0.05,

^bP < 0.01 vs group D;

^cP < 0.05,

^dP < 0.01 vs group E;

^eP < 0.05 vs group F. APCS: Asia-Pacific colorectal screening; MR: Moderate-risk; HR: High-risk.

Full Size Table

Citation: Wang JY, Li ZT, Zhu YM, Wang WC, Ma Y, Liu YL. Utility of the Asia-Pacific colorectal screening scoring system and the presence of metabolic syndrome components in screening for sporadic colorectal cancer. World J Gastroenterol 2014; 20(32): 11394-11399
URL: https://www.wjgnet.com/1007-9327/full/v20/i32/11394.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i32.11394